OR
Ortin Global Ltd (ORTINGLOBE)
₹14.44
Mkt cap
₹13 Cr
P/E ratio
—
P/B
9.50
Div yield
0.00%
ROE
−46.00%
ROCE
−32.10%
EPS (TTM)
—
Book value
₹2
52W range
11–21
Sector
Healthcare
Price history
Previous close
Incorporated in 1986, Ortin Laboratories Ltd manufactures pharmaceutical formulations. [1]
NSE ORTINGLOBEBSE 539287
Health check
Cautious
ProfitabilityWeak
GrowthLow
TechnicalsNeutral
52-week range
−32.21% from high₹14
₹11+35.46% from low₹21
Current
₹14.44
Prev close
₹13.82
Day
+4.49%
Price performance
1D
+4.49%
1W
−1.43%
1M
−3.86%
3M
−15.51%
6M
+1.62%
1Y
+26.67%
YTD
+2.05%
Financials
Revenue, profit & margin
| Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 | Trend | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 1.57 | 0.27 | 0.14 | 0.30 | 0.21 | 0.05 | 0.03 | 0.09 | 0.08 | 0.01 | 0.01 | 0.30 | 0.01 | |
| Expenses | 1.39 | 1.17 | 2.74 | 3.35 | 0.31 | 0.50 | 0.16 | 0.25 | 0.24 | 0.51 | 0.06 | 0.31 | 0.34 | |
| Operating Profit | 0.18 | -0.90 | -2.60 | -3.05 | -0.10 | -0.45 | -0.13 | -0.16 | -0.16 | -0.50 | -0.05 | -0.01 | -0.33 | |
| OPM % | 11.46% | -333.33% | -1,857.14% | -1,016.67% | -47.62% | -900.00% | -433.33% | -177.78% | -200.00% | -5,000.00% | -500.00% | -3.33% | -3,300.00% | |
| Other Income | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.02 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Interest | 0.11 | 0.15 | 0.14 | 0.08 | 0.00 | 0.02 | -0.01 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Depreciation | 0.06 | 0.06 | 0.06 | 0.05 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Profit before tax | 0.01 | -1.11 | -2.80 | -3.18 | -0.10 | -0.47 | -0.10 | -0.16 | -0.16 | -0.50 | -0.05 | -0.01 | -0.33 | |
| Tax % | 0.00% | 1.80% | -0.71% | 30.19% | 0.00% | 0.00% | 10.00% | 0.00% | 6.25% | 0.00% | 0.00% | 0.00% | 0.00% | |
| Net Profit | 0.02 | -1.12 | -2.79 | -4.14 | -0.10 | -0.47 | -0.11 | -0.16 | -0.18 | -0.50 | -0.05 | -0.01 | -0.34 | |
| EPS in Rs | 0.02 | -1.38 | -3.43 | -5.09 | -0.12 | -0.58 | -0.14 | -0.20 | -0.22 | -0.61 | -0.06 | -0.01 | -0.42 | |
| Raw PDF |
Earnings
Results dates & reactionsNo upcoming results date on calendar.
Fresh quarters land in the Financials table above, tagged NSE until screener catches up.
Avg earnings-day move +0.57% · closed higher next day 0 of last 1
| Q1FY27 | |
|---|---|
| Broadcast | 14 Aug '26◦ |
| Earnings day | +0.57% |
| +1 day | −0.06% |
| +5 days | −3.23% |
| +15 days | −2.28% |
| +30 days | −6.84% |
| Filing | XBRL |
Corporate actions
Last 6 monthsNo recent corporate actions
Dividends, splits, and bonuses in the last six months show up here.
Results analysis
Shareholding
as of Jun 20261.23%Promoter
Promoters1.23%
FIIs1.80%0.12
Public96.96%0.14
Ownership trend
Peers
8 companiesValuation vs quality
P/E × ROCE · bubble = market cap| Name | CMP | P/E | Mkt Cap | Div Yld | NP Qtr | Qtr Profit Var | Sales Qtr | Qtr Sales Var | ROCE |
|---|---|---|---|---|---|---|---|---|---|
| Sun Pharma.Inds. | ₹1,837.30 | 34.90 | 4,40,830 | 0.87% | 2,901 | +5.95% | 15,300 | +10.46% | 20.53% |
| Divi's Lab. | ₹9,375.00 | 83.54 | 2,48,877 | 0.32% | 902 | +65.50% | 3,080 | +27.80% | 21.97% |
| Torrent Pharma. | ₹4,840.00 | 82.51 | 1,84,098 | 0.79% | 566 | +5.79% | 4,921 | +54.85% | 15.19% |
| Zydus Lifesci. | ₹1,160.00 | 23.77 | 1,15,710 | 0.09% | 990 | −35.09% | 8,017 | +21.96% | 21.14% |
| Cipla | ₹1,394.50 | 31.48 | 1,12,656 | 0.93% | 786 | −39.19% | 7,119 | +2.33% | 15.49% |
| Laurus Labs | ₹1,954.00 | 96.56 | 1,05,577 | 0.10% | 362 | +125.49% | 2,026 | +29.10% | 17.76% |
| Aurobindo Pharma | ₹1,734.00 | 26.39 | 99,771 | 0.23% | 1,032 | +28.11% | 9,150 | +16.30% | 12.86% |
| Ortin Global | ₹15.83 | — | 13 | 0.00% | 0 | −88.89% | 0 | −87.50% | −32.14% |
| Median: 158 Co. | ₹433.90 | 34.56 | 2,205 | 0.08% | 13 | +29.57% | 164 | +18.57% | 14.96% |
Filings
Annual reports15
Announcements5
Reg. 34 (1) Annual Report. 8 SepNotice Of AGM For The FY 2025-26 Scheduled To Be Held On 30.09.2026 8 Sep - AGM on 30 Sep 2026; board approved director role changes and Parveen Satija appointment effective 7 Sep 2026.Resignation Letter 8 Sep - Prakruti Prashant Sawant resigns as Whole-time Director effective 07.09.2026.Announcement under Regulation 30 (LODR)-Change in Management 7 Sep - Board approved MD change, WTD resignation/appointment, and AGM on 30 Sep 2026.Board Meeting Outcome for Outcome Of Board Meeting 7 Sep - Board approved MD/WTD changes; Parveen Satija appointed; AGM on 30 Sept 2026.